HSIC

Q: What is the price of Henry Schein (HSIC) today?

The current price of Henry Schein (HSIC) is $84.95. The stock began the year trading around $75.58 and is currently priced at $84.95. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Henry Schein (HSIC) pay dividends?

Henry Schein (HSIC) did not pay dividends over the past year.

Q: Is Henry Schein (HSIC) a good investment?

Henry Schein (HSIC) is currently trading at $84.95 with a P/E ratio of 24.73. This represents a 2,258% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 15.94%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Henry Schein Inc.

Price

$84.95

return (12m)

15.94%

p/e

24.73

p/bv

2.03

DIVIDEND YIELD

0.00%

HSIC price

Henry Schein

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HSIC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.31%

3 months

17.82%

1 year

15.94%

2 years

32.55%

5 years

14.80%

10 years

-3.85%

Fundamentals HSIC

review the fundamentals of Henry Schein shares

P/E

24.73

Sector: -2.39 Industry: 0.26

P/S (PSR)

0.73

Sector: 1.92 Industry: 2.29

P/BV

2.03

Sector: 2.11 Industry: 2.32

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

3.49%

Sector: -28.32% Industry: -26.72%

ROE

8.19%

Sector: -34.65% Industry: -37.12%

ROIC

6.53%

Sector: -441.72% Industry: -95.80%

NET MARGIN

2.95%

Sector: -30.29% Industry: -32.16%

GROSS MARGIN

31.19%

Sector: 44.79% Industry: 49.43%

OPERATING MARGIN

5.62%

Sector: -25.24% Industry: -28.71%

EV/EBITDA

9.79

Sector: -0.42 Industry: 0.65

EV/EBIT

14.12

Sector: -2.07 Industry: -0.68

PRICE-TO-ASSETS

0.86

Sector: 1.15 Industry: 1.26

BVPS

41.93

Sector: 3.82 Industry: 5.02

EPS

3.43

Sector: -0.93 Industry: -0.78

EQUITY-TO-ASSETS RATIO

0.43

Sector: 0.43 Industry: 0.45

LIABILITIES / ASSETS

0.57

Sector: 0.47 Industry: 0.51

CAGR REVENUE 5 YEARS

1.54%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-8.94%

Sector: - Industry: -

FAIR VALUE OF Henry Schein ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$84.95

Fair Value

$56.89

Upside Return potential.

-33.04%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals HSIC

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
HSIC	24.73	2.03	8.19%	0.00%	$9.77 B	2.95%
LLY	42.78	34.66	81.02%	0.53%	$1.08 T	34.99%
ISRG	48.23	8.16	16.93%	0.00%	$143.67 B	28.15%
SNY	7.02	1.25	17.79%	4.11%	$104.84 B	14.75%
NVS	21.92	7.62	34.77%	2.00%	$296.68 B	23.92%
TMO	27.87	3.67	13.15%	0.34%	$190.85 B	15.15%
ABT	23.76	2.83	11.91%	2.85%	$149.12 B	13.91%
MDT	21.61	2.07	9.59%	3.51%	$103.74 B	13.20%
GSK	13.35	4.51	33.77%	3.37%	$104.74 B	17.79%
CVS	45.30	1.71	3.78%	2.55%	$132.82 B	0.72%
BSX	18.55	2.56	13.78%	0.00%	$66.12 B	17.29%
TMDX	13.53	4.71	34.80%	0.00%	$2.33 B	27.04%
IDXX	40.28	28.35	70.38%	0.00%	$44.12 B	24.63%
HCA	12.91	-29.46	-228.14%	0.75%	$87.74 B	8.89%
RMD	19.11	4.47	23.41%	1.20%	$29.04 B	27.44%
DHR	37.65	2.62	6.97%	0.69%	$138.90 B	14.89%
PHG	22.84	1.95	8.56%	3.74%	$25.80 B	5.50%
INMD	10.57	1.39	13.18%	0.00%	$921.69 M	23.27%
COHR	154.22	6.56	4.26%	0.00%	$72.31 B	7.10%
SYK	38.09	5.53	14.52%	1.04%	$127.09 B	13.21%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

HSIC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Henry Schein

Henry Schein Inc.

Average Investor10 user rating

4.0 (4 people)

United States

34 years

Founded: 1992

1995

Time since IPO - 31 years

19.000

Employees

Henry Schein Inc. (United States) is listed on the Nasdaq and has a market capitalization of $9.77 billion, with shareholders equity totaling $4.82 billion.

The company employs approximately 19.000 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Henry Schein Inc. reported $13.38 billion in revenue, generating net income of $395.00 million.

Key financial metrics include a P/E ratio of 24.73, a price-to-book (P/B) ratio of 2.03, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HSIC.

Market cap

$9.77 billion

Net worth

$4.82 billion

$4,822,000,000.00

Assets

$11.30 billion

$11,304,000,000.00

Total Shares Outstanding

115.00 million

115,000,000

Average Daily Trading Volume

$1.52 million

$1,520,608.74

Sector

Health

Industry

Medical Supplies and Equipment

HSIC

HSIC revenue and profits

Financial Results HSIC

DRAG THE FRAME TO SEE MORE DATA

HSIC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$104.34 57,90% (12M)

P/E

45.30

2.55%

ROE

3.78%

P/BV

1.71

CI - Cigna

$282.79 --11,43% (12M)

P/E

11.50

2.17%

ROE

15.39%

P/BV

1.77

CNC - Centene

$65.73 21,74% (12M)

P/E

-5.02

0.00%

ROE

-29.93%

P/BV

1.50

HUM - Humana

$383.84 61,19% (12M)

P/E

40.76

0.92%

ROE

6.06%

P/BV

2.47

SNY - Sanofi

$42.95 --6,70% (12M)

P/E

7.02

4.11%

ROE

17.79%

P/BV

1.25

LLY - Eli Lilly

$1,208.12 56,08% (12M)

P/E

42.78

0.53%

ROE

81.02%

P/BV

34.66

HCA - HCA Healthcare

$391.68 4,15% (12M)

P/E

12.91

0.75%

ROE

-228.14%

P/BV

-29.46

NVS - Novartis

$155.41 32,01% (12M)

P/E

21.92

2.00%

ROE

34.77%

P/BV

7.62